APO RESEARCH · REPORT
Plasma Therapy
Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
Product & engineering
Understand the product.
Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
Selected research
Industry Research
Plasma Therapy Industry Research Report 2026
Market perspective
Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
North America is the largest consumption place, with a consumption market share nearly 53% . Europe is the second largest consumption place with the consumption market share of 26%. Terumo, Arthrex, Zimmer Biomet, DePuy Synthes and EmCyte are the leaders of the industry, top 3 companies occupied about 55% market share.
Report Scope
Read the full market overview
This report quantifies the global Plasma Therapy market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Plasma Therapy.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Plasma Therapy Market by Company
Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics
Plasma Therapy Segment by Type
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)
Plasma Therapy Segment by Application
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Plasma Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Plasma Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pure PRP
- Leucocyte-rich PRP
- Leukocyte-rich Fibrin (L-PRF)
Applications
- Orthopedic
- Darmatology
- Cardiac Muscle Injury
- Dental
- Nerve Injury
Companies covered
- Terumo
- Arthrex
- Zimmer Biomet
- DePuy Synthes
- EmCyte
- Regen Lab
- ISTO Biologics
- Cesca Therapeutics
- Weigao
- REV-MED
- Nuo Therapeutics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Plasma Therapy by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Pure PRP
- 2.2.3 Leucocyte-rich PRP
- 2.2.4 Leukocyte-rich Fibrin (L-PRF)
- 2.3 Plasma Therapy by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Orthopedic
- 2.3.3 Darmatology
- 2.3.4 Cardiac Muscle Injury
- 2.3.5 Dental
- 2.3.6 Nerve Injury
- 2.4 Assumptions and Limitations
3 Plasma Therapy Breakdown Data by Type
- 3.1 Global Plasma Therapy Historic Market Size by Type (2021-2026)
- 3.2 Global Plasma Therapy Forecasted Market Size by Type (2027-2032)
4 Plasma Therapy Breakdown Data by Application
- 4.1 Global Plasma Therapy Historic Market Size by Application (2021-2026)
- 4.2 Global Plasma Therapy Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Plasma Therapy Market Perspective (2021-2032)
- 5.2 Global Plasma Therapy Growth Trends by Region
- 5.2.1 Global Plasma Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Plasma Therapy Historic Market Size by Region (2021-2026)
- 5.2.3 Plasma Therapy Forecasted Market Size by Region (2027-2032)
- 5.3 Plasma Therapy Market Dynamics
- 5.3.1 Plasma Therapy Industry Trends
- 5.3.2 Plasma Therapy Market Drivers
- 5.3.3 Plasma Therapy Market Challenges
- 5.3.4 Plasma Therapy Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Plasma Therapy Players by Revenue
- 6.1.1 Global Top Plasma Therapy Players by Revenue (2021-2026)
- 6.1.2 Global Plasma Therapy Revenue Market Share by Players (2021-2026)
- 6.2 Global Plasma Therapy Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Plasma Therapy Head Office and Area Served
- 6.4 Global Plasma Therapy Players, Product Type & Application
- 6.5 Global Plasma Therapy Manufacturers Established Date
- 6.6 Global Plasma Therapy Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Plasma Therapy Market Size (2021-2032)
- 7.2 North America Plasma Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Plasma Therapy Market Size by Country (2021-2026)
- 7.4 North America Plasma Therapy Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Plasma Therapy Market Size (2021-2032)
- 8.2 Europe Plasma Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Plasma Therapy Market Size by Country (2021-2026)
- 8.4 Europe Plasma Therapy Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Plasma Therapy Market Size (2021-2032)
- 9.2 Asia-Pacific Plasma Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Plasma Therapy Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Plasma Therapy Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Plasma Therapy Market Size (2021-2032)
- 10.2 South America Plasma Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Plasma Therapy Market Size by Country (2021-2026)
- 10.4 South America Plasma Therapy Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Plasma Therapy Market Size (2021-2032)
- 11.2 Middle East & Africa Plasma Therapy Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Plasma Therapy Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Plasma Therapy Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Terumo
- 12.1.1 Terumo Company Information
- 12.1.2 Terumo Business Overview
- 12.1.3 Terumo Revenue in Plasma Therapy Business (2021-2026)
- 12.1.4 Terumo Plasma Therapy Product Portfolio
- 12.1.5 Terumo Recent Developments
- 12.2 Arthrex
- 12.2.1 Arthrex Company Information
- 12.2.2 Arthrex Business Overview
- 12.2.3 Arthrex Revenue in Plasma Therapy Business (2021-2026)
- 12.2.4 Arthrex Plasma Therapy Product Portfolio
- 12.2.5 Arthrex Recent Developments
- 12.3 Zimmer Biomet
- 12.3.1 Zimmer Biomet Company Information
- 12.3.2 Zimmer Biomet Business Overview
- 12.3.3 Zimmer Biomet Revenue in Plasma Therapy Business (2021-2026)
- 12.3.4 Zimmer Biomet Plasma Therapy Product Portfolio
- 12.3.5 Zimmer Biomet Recent Developments
- 12.4 DePuy Synthes
- 12.4.1 DePuy Synthes Company Information
- 12.4.2 DePuy Synthes Business Overview
- 12.4.3 DePuy Synthes Revenue in Plasma Therapy Business (2021-2026)
- 12.4.4 DePuy Synthes Plasma Therapy Product Portfolio
- 12.4.5 DePuy Synthes Recent Developments
- 12.5 EmCyte
- 12.5.1 EmCyte Company Information
- 12.5.2 EmCyte Business Overview
- 12.5.3 EmCyte Revenue in Plasma Therapy Business (2021-2026)
- 12.5.4 EmCyte Plasma Therapy Product Portfolio
- 12.5.5 EmCyte Recent Developments
- 12.6 Regen Lab
- 12.6.1 Regen Lab Company Information
- 12.6.2 Regen Lab Business Overview
- 12.6.3 Regen Lab Revenue in Plasma Therapy Business (2021-2026)
- 12.6.4 Regen Lab Plasma Therapy Product Portfolio
- 12.6.5 Regen Lab Recent Developments
- 12.7 ISTO Biologics
- 12.7.1 ISTO Biologics Company Information
- 12.7.2 ISTO Biologics Business Overview
- 12.7.3 ISTO Biologics Revenue in Plasma Therapy Business (2021-2026)
- 12.7.4 ISTO Biologics Plasma Therapy Product Portfolio
- 12.7.5 ISTO Biologics Recent Developments
- 12.8 Cesca Therapeutics
- 12.8.1 Cesca Therapeutics Company Information
- 12.8.2 Cesca Therapeutics Business Overview
- 12.8.3 Cesca Therapeutics Revenue in Plasma Therapy Business (2021-2026)
- 12.8.4 Cesca Therapeutics Plasma Therapy Product Portfolio
- 12.8.5 Cesca Therapeutics Recent Developments
- 12.9 Weigao
- 12.9.1 Weigao Company Information
- 12.9.2 Weigao Business Overview
- 12.9.3 Weigao Revenue in Plasma Therapy Business (2021-2026)
- 12.9.4 Weigao Plasma Therapy Product Portfolio
- 12.9.5 Weigao Recent Developments
- 12.10 REV-MED
- 12.10.1 REV-MED Company Information
- 12.10.2 REV-MED Business Overview
- 12.10.3 REV-MED Revenue in Plasma Therapy Business (2021-2026)
- 12.10.4 REV-MED Plasma Therapy Product Portfolio
- 12.10.5 REV-MED Recent Developments
- 12.11 Nuo Therapeutics
- 12.11.1 Nuo Therapeutics Company Information
- 12.11.2 Nuo Therapeutics Business Overview
- 12.11.3 Nuo Therapeutics Revenue in Plasma Therapy Business (2021-2026)
- 12.11.4 Nuo Therapeutics Plasma Therapy Product Portfolio
- 12.11.5 Nuo Therapeutics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst